This announcement is a separate document:
Medibio Ltd: Phase 2 Trial Commences for SAMDE Study
Sep 4, 2023 06:30
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
23:00
Goldman Sachs maintains its forecast of an average Brent crude oil product price of $76 per barrel for 2025.
GS+0.09%
22:58
The Japan Ministry of Defense announced the first five test launches of the improved "Type 12 Surface-to-Ship Missile."
22:57
Alcoa (AA) in the usa fell by 9.4%, marking its worst intraday performance since March 2023.
AA-8.45%